201 related articles for article (PubMed ID: 2502567)
1. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections.
Gilbert M
J Am Acad Dermatol; 1989 Jun; 20(6):1083-7. PubMed ID: 2502567
[TBL] [Abstract][Full Text] [Related]
2. Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate.
White DG; Collins PO; Rowsell RB
J Infect; 1989 May; 18(3):221-9. PubMed ID: 2501394
[TBL] [Abstract][Full Text] [Related]
3. A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis.
Morley PA; Munot LD
Curr Med Res Opin; 1988; 11(2):142-8. PubMed ID: 3146465
[TBL] [Abstract][Full Text] [Related]
4. Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections.
Johnston C
J Am Acad Dermatol; 1991 May; 24(5 Pt 1):797-8. PubMed ID: 1907980
[No Abstract] [Full Text] [Related]
5. [Comparative double-blind evaluation of a new topical antibacterial agent, mupirocin, compared with placebo in the treatment of skin and soft tissue infections].
Colin M; Avon P
Pharmatherapeutica; 1988; 5(3):198-203. PubMed ID: 3129741
[TBL] [Abstract][Full Text] [Related]
6. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections.
Odom RB
Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial.
Bork K; Brauers J; Kresken M
Br J Clin Pract; 1989 Aug; 43(8):284-8. PubMed ID: 2516463
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P
Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167
[TBL] [Abstract][Full Text] [Related]
9. Fusidic acid in skin and soft tissue infections.
Spelman D
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S59-66. PubMed ID: 10528787
[TBL] [Abstract][Full Text] [Related]
10. Comparative double-blinded study between mupirocin and tetracycline ointments for treating skin infections.
Wong KS; Lim KB; Tham SN; Ling ML; Tan T
Singapore Med J; 1989 Aug; 30(4):380-3. PubMed ID: 2510312
[TBL] [Abstract][Full Text] [Related]
11. Fusidic acid in dermatology: an updated review.
Schöfer H; Simonsen L
Eur J Dermatol; 2010; 20(1):6-15. PubMed ID: 20007058
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection.
Boon RJ; Beale AS; Sutherland R
J Antimicrob Chemother; 1985 Oct; 16(4):519-26. PubMed ID: 3934130
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
Gisby J; Bryant J
Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonic acid--a new antibiotic for skin infections.
Reilly GD; Spencer RC
J Antimicrob Chemother; 1984 Mar; 13(3):295-8. PubMed ID: 6427173
[TBL] [Abstract][Full Text] [Related]
15. Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Ward A; Campoli-Richards DM
Drugs; 1986 Nov; 32(5):425-44. PubMed ID: 3098541
[TBL] [Abstract][Full Text] [Related]
16. Topical mupirocin in the treatment of bacterial skin infections.
Rumsfield J; West DP; Aronson IK
Drug Intell Clin Pharm; 1986 Dec; 20(12):943-8. PubMed ID: 3102197
[TBL] [Abstract][Full Text] [Related]
17. Infections after photodynamic therapy in Condyloma acuminatum patients: incidence and management.
Yu X; Zheng H
Environ Sci Pollut Res Int; 2018 May; 25(14):14000-14005. PubMed ID: 29516425
[TBL] [Abstract][Full Text] [Related]
18. Clinical and bacteriological efficacy of mupirocin (Bactroban): a new topical antibiotic.
Gould PW; Villiger JW
N Z Med J; 1986 Jul; 99(805):516. PubMed ID: 3090486
[No Abstract] [Full Text] [Related]
19. An evaluation of topical mupirocin in moderately severe primary and secondary skin infections.
Buchvald J
J Int Med Res; 1988; 16(1):66-70. PubMed ID: 3127257
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema.
Ravenscroft JC; Layton AM; Eady EA; Murtagh MS; Coates P; Walker M; Cove JH
Br J Dermatol; 2003 May; 148(5):1010-7. PubMed ID: 12786834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
